Department of Internal Medicine,
Section of Infectious Diseases,
Department of Internal Medicine, Section of Infectious Diseases
Priti Kumar has not added Biography.
If you are Priti Kumar and would like to personalize this page please email our Author Liaison for assistance.
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.
Journal of virology Mar, 2010 | Pubmed ID: 20015996
Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.
Chemistry & biology Sep, 2011 | Pubmed ID: 21944757
Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum.
The Journal of biological chemistry Jul, 2013 | Pubmed ID: 23729665
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice.
Molecular therapy. Nucleic acids Nov, 2013 | Pubmed ID: 24253260
Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNA.
Methods in molecular biology (Clifton, N.J.) , 2014 | Pubmed ID: 25030923
Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer.
Small (Weinheim an der Bergstrasse, Germany) May, 2015 | Pubmed ID: 25515928
Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.
Chemistry & biology Jan, 2015 | Pubmed ID: 25544044
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
Nature Jan, 2015 | Pubmed ID: 25561180
Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice.
Human gene therapy Sep, 2015 | Pubmed ID: 25953321
Cationic cell-penetrating peptides as vehicles for siRNA delivery.
Therapeutic delivery , 2015 | Pubmed ID: 25996046
Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.
Science (New York, N.Y.) Oct, 2015 | Pubmed ID: 26429886
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice.
Molecular therapy. Nucleic acids Jan, 2016 | Pubmed ID: 26812653
Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
Journal of drug targeting 04, 2017 | Pubmed ID: 27820977
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection.
Molecular pharmacology 04, 2017 | Pubmed ID: 28167742
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Molecular cell Aug, 2017 | Pubmed ID: 28803777
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.
Proceedings of the National Academy of Sciences of the United States of America 01, 2018 | Pubmed ID: 29279368
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.
Cell host & microbe Apr, 2018 | Pubmed ID: 29606496
Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection.
Proceedings of the National Academy of Sciences of the United States of America 08, 2018 | Pubmed ID: 30097540
Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia.
Scientific reports Oct, 2018 | Pubmed ID: 30301943
Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV.
Antiviral research Jul, 2019 | Pubmed ID: 31034849
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved